¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary visual area"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • secondary sexual character
    ÀÌÂ÷¼ºÂ¡
  • secondary shock
    ÀÌÂ÷¼îÅ©, ¼Ó¹ß¼îÅ©
  • secondary sterility
    ¼Ó¹ßºÒÀÓ
  • secondary suture
    ÀÌÂ÷ºÀÇÕ
  • secondary tuberculosis
    ¼Ó¹ß°áÇÙ
  • secondary wound closure
    ÀÌÂ÷»óóºÀÇÕ
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • complex visual discrimination
    º¹Çսð¢ºÐº°
  • central visual acuity
    Á߽ɽ÷Â
  • kinetic visual field
    µ¿Àû½Ã¾ß
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • static visual field
    Á¤Àû½Ã¾ß
  • stereoscopic visual acuity
    ÀÔü½Ã·Â
  • visual
    ½Ã·Â-, ½Ã°¢-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • secondary process thinking
    ÀÌÂ÷°úÁ¤»ç°í
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • central visual acuity
    Á߽ɽ÷Â
  • stereoscopic visual acuity
    ÀÔü½Ã·Â
  • visual acuity
    ½Ã·Â
  • visual agnosia
    ½Ã°¢ÀνĺҴÉÁõ
  • visual angle
    ½Ã°¢°¢
  • visual aphasia
    (¢¡optic aphasia) ½Ã°¢¾ð¾î»ó½ÇÁõ
  • visual aura
    ½Ã°¢Á¶Áü
  • visual axis
    ½Ã¼±Ãà, ½ÃÃà
  • complex visual discrimination
    º¹Çսð¢ºÐº°
  • visual cell
    ½Ã°¢¼¼Æ÷
  • visual center
    ½Ã°¢ÁßÃß
  • visual cone
    (¢¡ocular cone) ½Ã°¢¿ø»Ô
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • area (foveae) centralis<³ª>
    Á᫐ ¿Í.
  • area acustica<³ª>
    û¾ß(ôéå¯).
  • area amniotica<³ª>
    ¾ç¸·ºÎ(åÏØ¯Ý»).
  • area cerebrovasculosa
    ³úÇ÷°ü±¸¿ª(Òàúìηϡæ´)
  • area craniovasculosae<³ª>
    µÎ°³Ç÷°ü±¸¿ª.
  • area cribrosa
    ü±¸¿ª
  • area entorhinalis <³ª>
    ³»ºñ¾ß
  • area germinativa<³ª>
    ¹è¹Ý(ÛÏÚè).
  • area monitoring
    ±¸¿ª<¹æ»çÇÇÆø>°¨½Ã.
  • area of facial nerve
    ¾ó±¼½Å°æ±¸¿ª
  • area paraterminalis<³ª>
    Á¾¸»ÆÇ¿·±¸¿ª.
  • area pellucida
    Åõ¸í±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • area praeterminalis<³ª>
    ÀüÁ¾¸»±¸¿ª.
  • area sampling
    Áö¿ªÃßÃâ¹ý(̤Ëç̧̧ËÑ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • visual acuity
    ½Ã·Â(ãÊæ³)
  • visual acuity
    ½Ã·Â(ãÊæ³).
  • visual acuity test
    ½Ã·Â°Ë»ç(¡­ËþÞÛ)
  • visual acuity test
    ½Ã·Â°Ë»ç(¡­ËþÞÛ).
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥, ½Ã½Ã·ÂÇ¥(ãËãÊæ³øú)
  • visual acuity test chart
    ½Ã½Ã·ÂÇ¥(ãËãÊæ³øú), ½Ã·Â°Ë»çÇ¥.
  • visual agnosia
    ½Ã°¢½ÇÀÎÁõ
  • visual agnosis
    ½Ã°¢½ÇÀÎ(ãÊÊÆã÷ìã).
  • visual agnosis
    ½Ã°¢½ÇÀÎ(ãÊÊÆã÷ìã)
  • visual aids
    ½Ã·Âº¸Á¶±â
  • visual allachesthesia
    À̼ҽð¢
  • visual angle
    ½Ã°¢(ãÊÊÇ)
  • visual angle
    ½Ã°¢(ãÊÊÇ).
  • visual aphasia
    ½Ã°¢¼º ½Ç¾îÁõ(¡­ã÷åÞñø).
  • visual aphasia
    ½Ã°¢¼º ½Ç¾îÁõ(¡­ã÷åÞñø)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Secondary tympanic membrane
    µÑ°°í¸·
    [¿¾ ¿ë¾î] Á¦ÀÌ°í¸·
  • Secondary spiral lamina
    µÑ°³ª¼±ÆÇ
    [¿¾ ¿ë¾î] Á¦2³ª¼±ÆÇ
  • Secondary fissure
    µÑ°ƴ»õ
    [¿¾ ¿ë¾î] Á¦2¿­
  • Secondary polar body
    ÀÌÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÌÂ÷±ØÃ¼
  • Secondary oocyte
    ÀÌÂ÷³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­¸ð¼¼Æ÷
  • Secondary oocyte, Metaphase II
    ÀÌÂ÷³­¸ð¼¼Æ÷, ÀÌÂ÷°¨¼öºÐ¿­Áß±â
    [¿¾ ¿ë¾î] Á¦À̳­¸ð¼¼Æ÷,ÀÌÂ÷Áß±â
  • Secondary follicle
    ÀÌÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­Æ÷
  • Secondary ovarian follicle
    ÀÌÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­Æ÷
  • Secondary visceral nucleus
    ÀÌÂ÷³»Àå½Å°æÇÙ
    [¿¾ ¿ë¾î] Á¦2Àå½Å°æÇÙ
  • Secondary abdominal implantation
    ÀÌÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÌÂ÷Àûº¹ºÎÂø»ó
  • Secondary bone
    ÀÌÂ÷»À
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ
  • Secondary osteon
    ÀÌÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¿ø
  • Secondary osteogenic bud
    ÀÌÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÇü¼º¾Æ
  • Secondary ossification center
    ÀÌÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary ossification center [Epiphyseal ossification cente
    ÀÌÂ÷»À¹ß»ýÁ᫐ [»À³¡»À¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • super-secondary structure
    ÃÊÀÌÂ÷ ±¸Á¶(õ±ì£ó­Ï°ðã)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • skip area
    °Ç³Ê¶Ú °÷
  • speech area
    ¾ð¾î¿µ¿ª
  • WAN (wide area network)
    ±¤¿ªÅë½Å¸Á
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
CPSC congenital paucity of secondary synaptic clefts [syndrome]; Consumer Products Safety Commission
HSH hypomagnesemia with secondary hypocalcemia
HSRD hypertension secondary to renal disease
LSSA lipid-soluble secondary antioxidant
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SE secondary electron
SHPT secondary hyperparathyroidism
SMC secondary mesenchyme cell
SP-MS secondary progressive MS
BVRT Benton Visual Retention Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • secondary healing
    ÀÌÂ÷Àû Ä¡À¯, À̱â À¯ÇÕ
  • secondary herpes simplex
    ÀÌÂ÷Àû ±¸¼ø Æ÷Áø
  • secondary hyperalgesia
    ¼Ó¹ß¼º Åë°¢ °ú¹Î, ÀÌÂ÷Àû Åë°¢ °ú¹Î
    µ¿ÀǾî=secondary hy
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×Áø, ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×ÁøÁõ
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ °üÀýº´Áõ
  • secondary impression
    ÀÌÂ÷ Àλó
  • secondary inoculation
    ÀÌÂ÷ Á¢Á¾
  • secondary lesion
    ÀÌÂ÷¼º º´º¯, ÀÌÂ÷ ¹ßÁø, ¼Ó¹ßÁø
  • secondary local muscle soreness
    ¼Ó¹ß¼º ±¹¼Ò ±Ùµ¿Åë
  • secondary occlusal trauma
    ¼Ó¹ß¼º ±³ÇÕ ¿Ü»ó
    ÀÌ¹Ì Ä¡ÁÖ ÁúȯÀÌ ÀÖ´Â Ä¡¾Æ¿¡ °¡ÇØÁø °úµµÇÑ ±³ÇÕ·ÂÀ¸·Î ÀÎÇÑ Ä¡ÁÖ Á¶Á÷ÀÇ ¿Ü»ó.
  • secondary ossification center
    ÀÌÂ÷ °ñÈ­ Áß½É
  • secondary osteon
    ÀÌÂ÷ »À ´ÜÀ§
  • secondary pain
    ¼Ó¹ß¼º ÅëÁõ, Á¦ÀÌ µ¿Åë
    µ¿ÀǾî=referred
  • secondary palate
    ÀÌÂ÷ ±¸°³
  • secondary pathway
    ÀÌÂ÷ °æ·Î
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
visual purple <protein> Light sensitive pigment formed from retinal linked through a Schiff's base to opsin: rhodopsin is an integral membrane protein found in the discs of retinal rods and cones, comprising some 40% of the membrane. Vertebrate opsins are proteins of 38 kD.
See: bacteriorhodopsin.
(18 Nov 1997)
visual receptor cells The rod and cone cell's of the retina.
(05 Mar 2000)
visual-spatial agnosia The inability to localise objects or to appreciate distance, motion, and spatial relationships; caused by lesion in the occipital lobe.
Compare: simultanagnosia.
(05 Mar 2000)
visual threshold Threshold of visual sensation, the minimal light intensity evoking a visual sensation.
Synonym: achromatic threshold, minimum light threshold.
(05 Mar 2000)
visual violet A visual pigment, composed of 11-cis-retinal bound to an opsin, found in the cones of the retina.
Synonym: visual violet.
Origin: G. Ion, violet, + ops, eye, + -in
(05 Mar 2000)
visual yellow The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
primary visual cortex See: visual cortex.
(05 Mar 2000)
evoked potentials, visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.
(12 Dec 1998)
unformed visual hallucination Hallucination composed of sparks, lights, or bursting spheres of light.
(05 Mar 2000)
formed visual hallucination <psychiatry> Hallucination composed of scenes, often landscapes.
(05 Mar 2000)
functional visual loss An apparent loss of visual acuity or visual field with no substantiating physical signs; often due to a natural concern about visual loss combined with suggestibility and a fear of the worst; best treated with reassurance.
(05 Mar 2000)
CS2 secondary alkylsulfohydrolase <enzyme> From comamonas terrigena
Registry number: EC 3.1.6.-
Synonym: cs2 sa sulfohydrolase
(26 Jun 1999)
protein structure, secondary The stage in the development of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices and beta sheets. This is the first folding level of protein building.
(12 Dec 1998)
secondary Second or inferior in order of time, place or importance, derived from or consequent to a primary event or thing.
Origin: L. Secundarius, secundus = second
(18 Nov 1997)
secondary abdominal pregnancy A condition in which the embryo or foetus continues to grow in the abdominal cavity after its expulsion from the fallopian tube or other seat of its primary development.
Synonym: abdominocyesis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dry area
    (°Ç)µå¶óÀÌ ¿¡¾î¸®¾î(ÁöÇϽÇÀÇ È¯±â,䱤À» À§ÇÏ¿© ¸¸µé¾î ³õÀº µµ¶û)
  • elemental area
    È­¼Ò(ÅÚ·¹ºñÁ¯ È­¸éÀÇ Á÷»ç°¢Çü ±¸¿ª)
  • fringe area
    ÇÁ¸°Áö¿¡¾î¸®¾î(¶óµð¿À ÅÚ¸®ºñÁ¯ÀÇ ½Ãû ºÒ·® Áö¿ª)
  • goal area
    °ñ¿¡¾î¸®¾î
  • gray area
    (¾ç±Ø »çÀÌÀÇ)Áß°£ ¿µ¿ª;À̵µÀúµµ ¾Æ´Ñ(¾Ö¸ÅÇÑ)ºÎºÐ(»óȲ);=GREY AREA
  • grey area
    Á¤½Ä ¿øÈ£ ´ë»óÀº ¾Æ´Ï³ª ½Ç¾÷·üÀÌ ³ôÀº Áö¿ª;=GRAY AREA
  • impact area
    (ÆøÅº,¹Ì»çÀÏÀÇ)ÀÛ·ÂÁö¿ª;ÂøÅºÁö¿ª
  • impacted area
    Àα¸ ±ÞÁõÁö±¸
  • jump area
    (³«ÇÏ»ê ºÎ´ëÀÇ)³«ÇÏ ¿¹Á¤Áö (ÀûÁøÀÇ ÈĹæ)
  • metropolitan area
    (´ë)µµ½Ã±Ç
  • penalty area
    ¹úÄ¢ ±¸¿ª
  • resistance area
    =RESISTANCE LEVEL
  • restricted area
    ÃâÀÔ(ÅëÇà)±ÝÁö ±¸¿ª
  • service area
    ¾ç(½Ã)û ±¸¿ª
  • staging area
    (ÀüÁö¿¡·ÎÀÇ)Áý°á ±âÁö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á